Objective The effects of glycosylation of proteins are gaining more and more importance, e.g. requirements. Numerous production techniques of recombinant proteins as drugs are developed at the moment. The quality for the pharmaceutical effect of those drugs is often dependent on the glycosylation status. Therefore a constantglycosylation is most crucial and needs to be monitored. Healthcare Technologies has developed a system and reliable method of glycosylation fingerprinting. Phytowelt is working on the production of recombinant proteins in plants and normal profiling by coda micro arrays. To access the utility of this production system both companies aim to evaluate the compatibility of their diagnostic systems to develop a safe and cost efficient production method combined with a method to monitor product quality and reliability in a cost efficient way. Fields of science medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsnatural sciencesbiological sciencesbiochemistrybiomoleculesproteins Programme(s) FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002 Topic(s) 1.1.1.-3. - Key action The "Cell factory" Call for proposal Data not available Funding Scheme EAW - Exploratory awards Coordinator PHYTOWELT GMBH EU contribution No data Address Kölsumer Weg 33 41334 NETTETAL Germany See on map Total cost No data Participants (1) Sort alphabetically Sort by EU Contribution Expand all Collapse all HEALTHCARE TECHNOLOGIES LTD Israel EU contribution No data Address 3, habosem St., Kiryat Minrav, 77601 ASHDOD See on map Total cost No data
